Similar articles

• Treatment of depression in patients with coronary artery disease.

  Dornelas EA, Burg MM. Dornelas EA, et al. JAMA. 2007 May 2;297(17):1879-80; author reply 1880. doi: 10.1001/jama.297.17.1879. JAMA. 2007. PMID: 17473295 No abstract available.
• Treatment of depression in patients with coronary artery disease.

  Ziegelstein RC. Ziegelstein RC. JAMA. 2007 May 2;297(17):1878-9; author reply 1880. doi: 10.1001/jama.297.17.1878-b. JAMA. 2007. PMID: 17473294 No abstract available.
• Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

  Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC; CREATE Investigators. Lespérance F, et al. JAMA. 2007 Jan 24;297(4):367-79. doi: 10.1001/jama.297.4.367. JAMA. 2007. PMID: 17244833 Clinical Trial.
• Escitalopram (Lexapro) for depression.

  Masilamani S, Ruppelt SC. Masilamani S, et al. Am Fam Physician. 2003 Dec 1;68(11):2235-6. Am Fam Physician. 2003. PMID: 14677669 Review.
• Sertraline for the treatment of depression in coronary artery disease and heart failure.

  Parissis J, Fountoulaki K, Paraskevaidis I, Kremastinos DT. Parissis J, et al. Expert Opin Pharmacother. 2007 Jul;8(10):1529-37. doi: 10.1517/14656566.8.10.1529. Expert Opin Pharmacother. 2007. PMID: 17661734 Review.